A Study to Assess the Safety, Pharmacokinetics, and Anti-Tumor Activity of Oral HP518 in mCRPC Patients
Clinical trial NCT06155084 · RECRUITING
Trial details
- NCT number
- NCT06155084
- Sponsor
- Hinova Pharmaceuticals Inc.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-26
- Primary completion
- 2026-03-01
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.